| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | Rho-dependent protein serine/threonine kinase activity | 6.82e-07 | 2 | 17 | 2 | GO:0072518 | |
| GeneOntologyMolecularFunction | frizzled binding | 5.76e-06 | 42 | 17 | 3 | GO:0005109 | |
| GeneOntologyMolecularFunction | tau-protein kinase activity | 1.56e-04 | 22 | 17 | 2 | GO:0050321 | |
| GeneOntologyMolecularFunction | tau protein binding | 6.91e-04 | 46 | 17 | 2 | GO:0048156 | |
| GeneOntologyMolecularFunction | cytokine activity | 1.16e-03 | 250 | 17 | 3 | GO:0005125 | |
| GeneOntologyMolecularFunction | G protein-coupled receptor binding | 2.72e-03 | 337 | 17 | 3 | GO:0001664 | |
| GeneOntologyMolecularFunction | molecular function activator activity | 2.95e-03 | 1233 | 17 | 5 | GO:0140677 | |
| GeneOntologyBiologicalProcess | heart development | 1.23e-06 | 757 | 17 | 7 | GO:0007507 | |
| GeneOntologyBiologicalProcess | optic cup formation involved in camera-type eye development | 1.92e-06 | 3 | 17 | 2 | GO:0003408 | |
| GeneOntologyBiologicalProcess | regulation of angiotensin-activated signaling pathway | 3.83e-06 | 4 | 17 | 2 | GO:0110061 | |
| GeneOntologyBiologicalProcess | negative regulation of cell junction assembly | 4.86e-06 | 41 | 17 | 3 | GO:1901889 | |
| GeneOntologyBiologicalProcess | morphogenesis of an epithelium | 6.65e-06 | 619 | 17 | 6 | GO:0002009 | |
| GeneOntologyBiologicalProcess | establishment of cell polarity | 1.14e-05 | 177 | 17 | 4 | GO:0030010 | |
| GeneOntologyBiologicalProcess | negative regulation of bicellular tight junction assembly | 1.34e-05 | 7 | 17 | 2 | GO:1903347 | |
| GeneOntologyBiologicalProcess | embryonic morphogenesis | 1.49e-05 | 713 | 17 | 6 | GO:0048598 | |
| GeneOntologyBiologicalProcess | negative regulation of apoptotic process | 1.77e-05 | 1133 | 17 | 7 | GO:0043066 | |
| GeneOntologyBiologicalProcess | epithelial to mesenchymal transition | 1.96e-05 | 203 | 17 | 4 | GO:0001837 | |
| GeneOntologyBiologicalProcess | tissue morphogenesis | 1.99e-05 | 750 | 17 | 6 | GO:0048729 | |
| GeneOntologyBiologicalProcess | negative regulation of programmed cell death | 2.19e-05 | 1171 | 17 | 7 | GO:0043069 | |
| GeneOntologyBiologicalProcess | optic cup morphogenesis involved in camera-type eye development | 2.29e-05 | 9 | 17 | 2 | GO:0002072 | |
| GeneOntologyBiologicalProcess | convergent extension involved in gastrulation | 3.50e-05 | 11 | 17 | 2 | GO:0060027 | |
| GeneOntologyBiologicalProcess | positive regulation of intracellular signal transduction | 4.29e-05 | 1299 | 17 | 7 | GO:1902533 | |
| GeneOntologyBiologicalProcess | epithelial cell differentiation | 4.59e-05 | 870 | 17 | 6 | GO:0030855 | |
| GeneOntologyBiologicalProcess | Wnt signaling pathway | 4.64e-05 | 516 | 17 | 5 | GO:0016055 | |
| GeneOntologyBiologicalProcess | establishment or maintenance of cell polarity | 4.93e-05 | 257 | 17 | 4 | GO:0007163 | |
| GeneOntologyBiologicalProcess | positive regulation of connective tissue replacement | 4.96e-05 | 13 | 17 | 2 | GO:1905205 | |
| GeneOntologyBiologicalProcess | embryonic camera-type eye formation | 4.96e-05 | 13 | 17 | 2 | GO:0060900 | |
| GeneOntologyBiologicalProcess | extrinsic apoptotic signaling pathway via death domain receptors | 5.76e-05 | 93 | 17 | 3 | GO:0008625 | |
| GeneOntologyBiologicalProcess | epithelial cell development | 5.89e-05 | 269 | 17 | 4 | GO:0002064 | |
| GeneOntologyBiologicalProcess | cell-matrix adhesion | 5.98e-05 | 270 | 17 | 4 | GO:0007160 | |
| GeneOntologyBiologicalProcess | positive regulation of MAPK cascade | 7.50e-05 | 571 | 17 | 5 | GO:0043410 | |
| GeneOntologyBiologicalProcess | embryo development | 8.20e-05 | 1437 | 17 | 7 | GO:0009790 | |
| GeneOntologyBiologicalProcess | circulatory system development | 8.38e-05 | 1442 | 17 | 7 | GO:0072359 | |
| GeneOntologyBiologicalProcess | mesenchymal cell differentiation | 8.54e-05 | 296 | 17 | 4 | GO:0048762 | |
| GeneOntologyBiologicalProcess | epithelium development | 9.43e-05 | 1469 | 17 | 7 | GO:0060429 | |
| GeneOntologyBiologicalProcess | regulation of connective tissue replacement | 9.71e-05 | 18 | 17 | 2 | GO:1905203 | |
| GeneOntologyBiologicalProcess | positive regulation of non-canonical Wnt signaling pathway | 9.71e-05 | 18 | 17 | 2 | GO:2000052 | |
| GeneOntologyBiologicalProcess | positive regulation of cell cycle process | 9.83e-05 | 307 | 17 | 4 | GO:0090068 | |
| GeneOntologyBiologicalProcess | peptidyl-serine phosphorylation | 9.83e-05 | 307 | 17 | 4 | GO:0018105 | |
| GeneOntologyBiologicalProcess | anatomical structure formation involved in morphogenesis | 1.00e-04 | 1483 | 17 | 7 | GO:0048646 | |
| GeneOntologyBiologicalProcess | regulation of cytokine production | 1.05e-04 | 1010 | 17 | 6 | GO:0001817 | |
| GeneOntologyBiologicalProcess | convergent extension | 1.08e-04 | 19 | 17 | 2 | GO:0060026 | |
| GeneOntologyBiologicalProcess | peptidyl-threonine phosphorylation | 1.08e-04 | 115 | 17 | 3 | GO:0018107 | |
| GeneOntologyBiologicalProcess | peptidyl-serine modification | 1.14e-04 | 319 | 17 | 4 | GO:0018209 | |
| GeneOntologyBiologicalProcess | regulation of endothelial cell development | 1.20e-04 | 20 | 17 | 2 | GO:1901550 | |
| GeneOntologyBiologicalProcess | regulation of establishment of endothelial barrier | 1.20e-04 | 20 | 17 | 2 | GO:1903140 | |
| GeneOntologyBiologicalProcess | peptidyl-threonine modification | 1.39e-04 | 125 | 17 | 3 | GO:0018210 | |
| GeneOntologyBiologicalProcess | canonical Wnt signaling pathway | 1.52e-04 | 344 | 17 | 4 | GO:0060070 | |
| GeneOntologyBiologicalProcess | cytokine production | 1.61e-04 | 1091 | 17 | 6 | GO:0001816 | |
| GeneOntologyBiologicalProcess | angiotensin-activated signaling pathway | 1.75e-04 | 24 | 17 | 2 | GO:0038166 | |
| GeneOntologyBiologicalProcess | positive regulation of tissue remodeling | 1.75e-04 | 24 | 17 | 2 | GO:0034105 | |
| GeneOntologyBiologicalProcess | regulation of establishment of cell polarity | 1.90e-04 | 25 | 17 | 2 | GO:2000114 | |
| GeneOntologyBiologicalProcess | positive regulation of meiotic nuclear division | 2.05e-04 | 26 | 17 | 2 | GO:0045836 | |
| GeneOntologyBiologicalProcess | connective tissue replacement | 2.05e-04 | 26 | 17 | 2 | GO:0097709 | |
| GeneOntologyBiologicalProcess | mesenchyme development | 2.06e-04 | 372 | 17 | 4 | GO:0060485 | |
| GeneOntologyBiologicalProcess | skin development | 2.08e-04 | 373 | 17 | 4 | GO:0043588 | |
| GeneOntologyBiologicalProcess | apoptotic signaling pathway | 2.13e-04 | 713 | 17 | 5 | GO:0097190 | |
| GeneOntologyBiologicalProcess | regulation of bicellular tight junction assembly | 2.39e-04 | 28 | 17 | 2 | GO:2000810 | |
| GeneOntologyBiologicalProcess | polarized epithelial cell differentiation | 2.74e-04 | 30 | 17 | 2 | GO:0030859 | |
| GeneOntologyBiologicalProcess | negative regulation of phosphatase activity | 2.74e-04 | 30 | 17 | 2 | GO:0010923 | |
| GeneOntologyBiologicalProcess | regulation of establishment or maintenance of cell polarity | 2.74e-04 | 30 | 17 | 2 | GO:0032878 | |
| GeneOntologyBiologicalProcess | positive regulation of Wnt signaling pathway | 2.77e-04 | 158 | 17 | 3 | GO:0030177 | |
| GeneOntologyBiologicalProcess | positive regulation of cell cycle | 2.90e-04 | 407 | 17 | 4 | GO:0045787 | |
| GeneOntologyBiologicalProcess | regulation of synapse maturation | 2.93e-04 | 31 | 17 | 2 | GO:0090128 | |
| GeneOntologyBiologicalProcess | cell-substrate adhesion | 2.98e-04 | 410 | 17 | 4 | GO:0031589 | |
| GeneOntologyBiologicalProcess | regulation of non-canonical Wnt signaling pathway | 3.13e-04 | 32 | 17 | 2 | GO:2000050 | |
| GeneOntologyBiologicalProcess | embryonic camera-type eye morphogenesis | 3.13e-04 | 32 | 17 | 2 | GO:0048596 | |
| GeneOntologyBiologicalProcess | negative regulation of biomineral tissue development | 3.13e-04 | 32 | 17 | 2 | GO:0070168 | |
| GeneOntologyBiologicalProcess | epithelial tube morphogenesis | 3.30e-04 | 421 | 17 | 4 | GO:0060562 | |
| GeneOntologyBiologicalProcess | camera-type eye development | 3.45e-04 | 426 | 17 | 4 | GO:0043010 | |
| GeneOntologyBiologicalProcess | camera-type eye morphogenesis | 3.50e-04 | 171 | 17 | 3 | GO:0048593 | |
| GeneOntologyBiologicalProcess | negative regulation of extrinsic apoptotic signaling pathway via death domain receptors | 3.53e-04 | 34 | 17 | 2 | GO:1902042 | |
| GeneOntologyBiologicalProcess | regulation of MAPK cascade | 3.96e-04 | 815 | 17 | 5 | GO:0043408 | |
| GeneOntologyBiologicalProcess | positive regulation of meiotic cell cycle | 4.19e-04 | 37 | 17 | 2 | GO:0051446 | |
| GeneOntologyBiologicalProcess | embryonic eye morphogenesis | 4.42e-04 | 38 | 17 | 2 | GO:0048048 | |
| GeneOntologyBiologicalProcess | neuron projection arborization | 4.42e-04 | 38 | 17 | 2 | GO:0140058 | |
| GeneOntologyBiologicalProcess | epidermis development | 4.65e-04 | 461 | 17 | 4 | GO:0008544 | |
| GeneOntologyBiologicalProcess | aortic valve morphogenesis | 4.65e-04 | 39 | 17 | 2 | GO:0003180 | |
| GeneOntologyBiologicalProcess | regulation of cell cycle process | 4.68e-04 | 845 | 17 | 5 | GO:0010564 | |
| GeneOntologyBiologicalProcess | keratinocyte differentiation | 4.68e-04 | 189 | 17 | 3 | GO:0030216 | |
| GeneOntologyBiologicalProcess | morphogenesis of embryonic epithelium | 4.76e-04 | 190 | 17 | 3 | GO:0016331 | |
| GeneOntologyBiologicalProcess | regulation of apoptotic signaling pathway | 4.88e-04 | 467 | 17 | 4 | GO:2001233 | |
| GeneOntologyBiologicalProcess | cellular response to angiotensin | 4.90e-04 | 40 | 17 | 2 | GO:1904385 | |
| GeneOntologyBiologicalProcess | regulation of keratinocyte differentiation | 4.90e-04 | 40 | 17 | 2 | GO:0045616 | |
| GeneOntologyBiologicalProcess | establishment of epithelial cell polarity | 5.40e-04 | 42 | 17 | 2 | GO:0090162 | |
| GeneOntologyBiologicalProcess | eye development | 5.42e-04 | 480 | 17 | 4 | GO:0001654 | |
| GeneOntologyBiologicalProcess | positive regulation of cellular component organization | 5.47e-04 | 1366 | 17 | 6 | GO:0051130 | |
| GeneOntologyBiologicalProcess | visual system development | 5.55e-04 | 483 | 17 | 4 | GO:0150063 | |
| GeneOntologyBiologicalProcess | regulation of tube diameter | 5.69e-04 | 202 | 17 | 3 | GO:0035296 | |
| GeneOntologyBiologicalProcess | blood vessel diameter maintenance | 5.69e-04 | 202 | 17 | 3 | GO:0097746 | |
| GeneOntologyBiologicalProcess | regulation of tube size | 5.77e-04 | 203 | 17 | 3 | GO:0035150 | |
| GeneOntologyBiologicalProcess | eye morphogenesis | 5.85e-04 | 204 | 17 | 3 | GO:0048592 | |
| GeneOntologyBiologicalProcess | sensory system development | 5.90e-04 | 491 | 17 | 4 | GO:0048880 | |
| GeneOntologyBiologicalProcess | negative regulation of dephosphorylation | 5.93e-04 | 44 | 17 | 2 | GO:0035305 | |
| GeneOntologyBiologicalProcess | cortical actin cytoskeleton organization | 6.20e-04 | 45 | 17 | 2 | GO:0030866 | |
| GeneOntologyBiologicalProcess | regulation of meiotic nuclear division | 6.20e-04 | 45 | 17 | 2 | GO:0040020 | |
| GeneOntologyBiologicalProcess | embryonic camera-type eye development | 6.20e-04 | 45 | 17 | 2 | GO:0031076 | |
| GeneOntologyBiologicalProcess | positive regulation of hydrolase activity | 6.27e-04 | 499 | 17 | 4 | GO:0051345 | |
| GeneOntologyBiologicalProcess | aortic valve development | 6.48e-04 | 46 | 17 | 2 | GO:0003176 | |
| GeneOntologyBiologicalProcess | regulation of epithelial cell differentiation | 7.00e-04 | 217 | 17 | 3 | GO:0030856 | |
| GeneOntologyBiologicalProcess | regulation of cell adhesion | 7.14e-04 | 927 | 17 | 5 | GO:0030155 | |
| GeneOntologyBiologicalProcess | MAPK cascade | 7.25e-04 | 930 | 17 | 5 | GO:0000165 | |
| GeneOntologyBiologicalProcess | cell cycle process | 7.28e-04 | 1441 | 17 | 6 | GO:0022402 | |
| GeneOntologyBiologicalProcess | positive regulation of gene expression | 7.41e-04 | 1446 | 17 | 6 | GO:0010628 | |
| GeneOntologyBiologicalProcess | regulation of amyloid-beta formation | 7.65e-04 | 50 | 17 | 2 | GO:1902003 | |
| GeneOntologyBiologicalProcess | semi-lunar valve development | 7.65e-04 | 50 | 17 | 2 | GO:1905314 | |
| GeneOntologyBiologicalProcess | synapse maturation | 7.65e-04 | 50 | 17 | 2 | GO:0060074 | |
| GeneOntologyCellularComponent | endoplasmic reticulum lumen | 1.26e-04 | 332 | 17 | 4 | GO:0005788 | |
| GeneOntologyCellularComponent | Schaffer collateral - CA1 synapse | 2.52e-04 | 155 | 17 | 3 | GO:0098685 | |
| GeneOntologyCellularComponent | cytoplasmic ribonucleoprotein granule | 1.25e-03 | 269 | 17 | 3 | GO:0036464 | |
| GeneOntologyCellularComponent | ribonucleoprotein granule | 1.51e-03 | 287 | 17 | 3 | GO:0035770 | |
| GeneOntologyCellularComponent | cell surface | 1.52e-03 | 1111 | 17 | 5 | GO:0009986 | |
| GeneOntologyCellularComponent | secretory granule lumen | 2.15e-03 | 325 | 17 | 3 | GO:0034774 | |
| GeneOntologyCellularComponent | cytoplasmic vesicle lumen | 2.25e-03 | 330 | 17 | 3 | GO:0060205 | |
| GeneOntologyCellularComponent | vesicle lumen | 2.29e-03 | 332 | 17 | 3 | GO:0031983 | |
| GeneOntologyCellularComponent | cytoplasmic stress granule | 2.71e-03 | 96 | 17 | 2 | GO:0010494 | |
| GeneOntologyCellularComponent | Golgi lumen | 3.48e-03 | 109 | 17 | 2 | GO:0005796 | |
| GeneOntologyCellularComponent | microtubule organizing center | 5.58e-03 | 919 | 17 | 4 | GO:0005815 | |
| GeneOntologyCellularComponent | centriole | 8.44e-03 | 172 | 17 | 2 | GO:0005814 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | 8.46e-03 | 530 | 17 | 3 | GO:0062023 | |
| MousePheno | ocular hypotension | 1.23e-05 | 5 | 16 | 2 | MP:0005260 | |
| MousePheno | pancreas cyst | 6.71e-05 | 11 | 16 | 2 | MP:0003336 | |
| Domain | Wnt | 6.01e-07 | 19 | 17 | 3 | IPR005817 | |
| Domain | WNT1 | 6.01e-07 | 19 | 17 | 3 | SM00097 | |
| Domain | Wnt_CS | 6.01e-07 | 19 | 17 | 3 | IPR018161 | |
| Domain | wnt | 6.01e-07 | 19 | 17 | 3 | PF00110 | |
| Domain | WNT1 | 6.01e-07 | 19 | 17 | 3 | PS00246 | |
| Domain | Rho_Binding | 7.80e-07 | 2 | 17 | 2 | PF08912 | |
| Domain | Rho-bd_dom | 7.80e-07 | 2 | 17 | 2 | IPR015008 | |
| Domain | ROCK1/ROCK2 | 7.80e-07 | 2 | 17 | 2 | IPR020684 | |
| Domain | HR1 | 2.18e-05 | 8 | 17 | 2 | PF02185 | |
| Domain | ZF_DAG_PE_1 | 2.52e-05 | 64 | 17 | 3 | PS00479 | |
| Domain | ZF_DAG_PE_2 | 2.52e-05 | 64 | 17 | 3 | PS50081 | |
| Domain | C1 | 2.64e-05 | 65 | 17 | 3 | SM00109 | |
| Domain | PE/DAG-bd | 2.77e-05 | 66 | 17 | 3 | IPR002219 | |
| Domain | Pkinase_C | 5.10e-04 | 37 | 17 | 2 | IPR017892 | |
| Domain | Pkinase_C | 6.57e-04 | 42 | 17 | 2 | PF00433 | |
| Domain | AGC-kinase_C | 1.17e-03 | 56 | 17 | 2 | IPR000961 | |
| Domain | AGC_KINASE_CTER | 1.17e-03 | 56 | 17 | 2 | PS51285 | |
| Domain | S_TK_X | 1.17e-03 | 56 | 17 | 2 | SM00133 | |
| Domain | C1_1 | 1.21e-03 | 57 | 17 | 2 | PF00130 | |
| Domain | V-set | 1.19e-02 | 184 | 17 | 2 | PF07686 | |
| Domain | Ig_V-set | 1.38e-02 | 199 | 17 | 2 | IPR013106 | |
| Domain | PH | 1.80e-02 | 229 | 17 | 2 | PF00169 | |
| Pathway | KEGG_WNT_SIGNALING_PATHWAY | 3.63e-07 | 151 | 15 | 5 | M19428 | |
| Pathway | KEGG_MEDICUS_REFERENCE_WNT_SIGNALING_MODULATION_WNT_ACYLATION | 9.35e-07 | 19 | 15 | 3 | M47836 | |
| Pathway | WP_POLYCYSTIC_KIDNEY_DISEASE_PATHWAY | 1.60e-06 | 85 | 15 | 4 | M48315 | |
| Pathway | REACTOME_WNT_LIGAND_BIOGENESIS_AND_TRAFFICKING | 2.21e-06 | 25 | 15 | 3 | MM14940 | |
| Pathway | REACTOME_WNT_LIGAND_BIOGENESIS_AND_TRAFFICKING | 2.50e-06 | 26 | 15 | 3 | M27239 | |
| Pathway | KEGG_MEDICUS_REFERENCE_WNT_SIGNALING_MODULATION_WNT_INHIBITOR | 3.14e-06 | 28 | 15 | 3 | M47835 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PTCH1_TO_HEDGEHOG_SIGNALING_PATHWAY | 3.50e-06 | 29 | 15 | 3 | M47372 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_SMO_TO_HEDGEHOG_SIGNALING_PATHWAY | 3.50e-06 | 29 | 15 | 3 | M47377 | |
| Pathway | WP_WNT_SIGNALING_WP428 | 4.99e-06 | 113 | 15 | 4 | M39669 | |
| Pathway | WP_WNT_SIGNALING_IN_KIDNEY_DISEASE | 6.81e-06 | 36 | 15 | 3 | M39699 | |
| Pathway | KEGG_MEDICUS_VARIANT_FZD7_OVEREXPRESSION_TO_WNT_SIGNALING_PATHWAY | 7.41e-06 | 37 | 15 | 3 | M47411 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_ESCHERICHIA_MAP_TO_LPA_GNA12_13_RHOA_SIGNALING_PATHWAY | 1.05e-05 | 5 | 15 | 2 | M49031 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_ROCKS | 1.05e-05 | 5 | 15 | 2 | MM15221 | |
| Pathway | WP_WNT_SIGNALING_IN_KIDNEY_DISEASE | 1.26e-05 | 44 | 15 | 3 | MM15878 | |
| Pathway | KEGG_MEDICUS_VARIANT_LRP6_OVEREXPRESSION_TO_WNT_SIGNALING_PATHWAY | 1.35e-05 | 45 | 15 | 3 | M47412 | |
| Pathway | KEGG_MEDICUS_REFERENCE_WNT_SIGNALING_PATHWAY | 1.44e-05 | 46 | 15 | 3 | M47409 | |
| Pathway | WP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_IN_COLORECTAL_CANCER | 2.03e-05 | 161 | 15 | 4 | M39770 | |
| Pathway | KEGG_BASAL_CELL_CARCINOMA | 2.47e-05 | 55 | 15 | 3 | M17807 | |
| Pathway | KEGG_HEDGEHOG_SIGNALING_PATHWAY | 2.61e-05 | 56 | 15 | 3 | M1053 | |
| Pathway | WP_WNT_SIGNALING | 3.38e-05 | 61 | 15 | 3 | MM15893 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CXCR4_GNA12_13_RHO_SIGNALING_PATHWAY | 3.79e-05 | 9 | 15 | 2 | M47546 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_SHIGELLA_IPAA_TO_ITGA_B_RHOGEF_RHOA_SIGNALING_PATHWAY | 5.78e-05 | 11 | 15 | 2 | M47721 | |
| Pathway | REACTOME_SEMA4D_INDUCED_CELL_MIGRATION_AND_GROWTH_CONE_COLLAPSE | 5.78e-05 | 11 | 15 | 2 | MM15046 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HCMV_US28_TO_GNA12_13_RHO_SIGNALING_PATHWAY | 8.19e-05 | 13 | 15 | 2 | M47547 | |
| Pathway | KEGG_MEDICUS_REFERENCE_LPA_GNA12_13_RHOA_SIGNALING_PATHWAY | 8.19e-05 | 13 | 15 | 2 | M47731 | |
| Pathway | WP_NCRNAS_INVOLVED_IN_WNT_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA | 1.05e-04 | 89 | 15 | 3 | M39563 | |
| Pathway | WNT_SIGNALING | 1.05e-04 | 89 | 15 | 3 | M5493 | |
| Pathway | PID_THROMBIN_PAR4_PATHWAY | 1.10e-04 | 15 | 15 | 2 | M138 | |
| Pathway | REACTOME_SEMA4D_IN_SEMAPHORIN_SIGNALING | 1.10e-04 | 15 | 15 | 2 | MM15037 | |
| Pathway | WP_AIRWAY_SMOOTH_MUSCLE_CELL_CONTRACTION | 1.26e-04 | 16 | 15 | 2 | M40060 | |
| Pathway | WP_CANCER_PATHWAYS | 1.31e-04 | 507 | 15 | 5 | M48302 | |
| Pathway | WP_LNCRNA_IN_CANONICAL_WNT_SIGNALING_AND_COLORECTAL_CANCER | 1.40e-04 | 98 | 15 | 3 | M39731 | |
| Pathway | WP_MICRORNAS_IN_CARDIOMYOCYTE_HYPERTROPHY | 1.44e-04 | 99 | 15 | 3 | MM15905 | |
| Pathway | WP_WNT_SIGNALING_PATHWAY_AND_PLURIPOTENCY | 1.53e-04 | 101 | 15 | 3 | MM15829 | |
| Pathway | KEGG_MELANOGENESIS | 1.53e-04 | 101 | 15 | 3 | M7761 | |
| Pathway | WP_WNT_SIGNALING_AND_PLURIPOTENCY | 1.53e-04 | 101 | 15 | 3 | M39387 | |
| Pathway | WP_MICRORNAS_IN_CARDIOMYOCYTE_HYPERTROPHY | 1.66e-04 | 104 | 15 | 3 | M39625 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_ROCKS | 1.79e-04 | 19 | 15 | 2 | M27493 | |
| Pathway | WP_DNA_DAMAGE_RESPONSE_ONLY_ATM_DEPENDENT | 1.96e-04 | 110 | 15 | 3 | M39492 | |
| Pathway | REACTOME_SEMA4D_INDUCED_CELL_MIGRATION_AND_GROWTH_CONE_COLLAPSE | 1.99e-04 | 20 | 15 | 2 | M18415 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_RHOA_SIGNALING_PATHWAY | 2.19e-04 | 21 | 15 | 2 | M47767 | |
| Pathway | WP_ESC_PLURIPOTENCY_PATHWAYS | 2.30e-04 | 116 | 15 | 3 | MM15863 | |
| Pathway | WP_EMBRYONIC_STEM_CELL_PLURIPOTENCY_PATHWAYS | 2.36e-04 | 117 | 15 | 3 | M39530 | |
| Pathway | WP_OSTEOBLAST_DIFFERENTIATION_AND_RELATED_DISEASES | 2.42e-04 | 118 | 15 | 3 | M39852 | |
| Pathway | REACTOME_RHOBTB1_GTPASE_CYCLE | 2.64e-04 | 23 | 15 | 2 | M41817 | |
| Pathway | REACTOME_SEMA4D_IN_SEMAPHORIN_SIGNALING | 2.88e-04 | 24 | 15 | 2 | M2243 | |
| Pathway | REACTOME_RHOBTB1_GTPASE_CYCLE | 3.13e-04 | 25 | 15 | 2 | MM15608 | |
| Pathway | REACTOME_EPHA_MEDIATED_GROWTH_CONE_COLLAPSE | 4.22e-04 | 29 | 15 | 2 | M27309 | |
| Pathway | PID_WNT_NONCANONICAL_PATHWAY | 5.15e-04 | 32 | 15 | 2 | M23 | |
| Pathway | WP_BREAST_CANCER_PATHWAY | 5.28e-04 | 154 | 15 | 3 | M39739 | |
| Pathway | REACTOME_SIGNALING_BY_GPCR | 5.97e-04 | 702 | 15 | 5 | M746 | |
| Pathway | SIG_REGULATION_OF_THE_ACTIN_CYTOSKELETON_BY_RHO_GTPASES | 6.16e-04 | 35 | 15 | 2 | M16801 | |
| Pathway | REACTOME_RHOBTB_GTPASE_CYCLE | 6.16e-04 | 35 | 15 | 2 | M41738 | |
| Pathway | REACTOME_RHOH_GTPASE_CYCLE | 6.52e-04 | 36 | 15 | 2 | MM15603 | |
| Pathway | REACTOME_RHOBTB_GTPASE_CYCLE | 6.89e-04 | 37 | 15 | 2 | MM15683 | |
| Pathway | REACTOME_RHOH_GTPASE_CYCLE | 6.89e-04 | 37 | 15 | 2 | M41813 | |
| Pathway | REACTOME_EPHB_MEDIATED_FORWARD_SIGNALING | 6.89e-04 | 37 | 15 | 2 | MM15022 | |
| Pathway | WP_G13_SIGNALING | 7.27e-04 | 38 | 15 | 2 | M39606 | |
| Pathway | WP_G13_SIGNALING_PATHWAY | 7.65e-04 | 39 | 15 | 2 | MM15898 | |
| Pathway | REACTOME_EPHB_MEDIATED_FORWARD_SIGNALING | 8.88e-04 | 42 | 15 | 2 | M27308 | |
| Pathway | PID_THROMBIN_PAR1_PATHWAY | 9.31e-04 | 43 | 15 | 2 | M238 | |
| Pathway | PID_RHOA_PATHWAY | 1.02e-03 | 45 | 15 | 2 | M12 | |
| Pathway | SIG_CHEMOTAXIS | 1.02e-03 | 45 | 15 | 2 | M5193 | |
| Pathway | REACTOME_SEMAPHORIN_INTERACTIONS | 1.31e-03 | 51 | 15 | 2 | MM14967 | |
| Pathway | WP_PATHOGENIC_ESCHERICHIA_COLI_INFECTION | 1.52e-03 | 55 | 15 | 2 | M39613 | |
| Pathway | KEGG_PATHOGENIC_ESCHERICHIA_COLI_INFECTION | 1.57e-03 | 56 | 15 | 2 | M2333 | |
| Pathway | REACTOME_SIGNALING_BY_WNT | 1.88e-03 | 239 | 15 | 3 | MM14756 | |
| Pathway | REACTOME_SEMAPHORIN_INTERACTIONS | 2.05e-03 | 64 | 15 | 2 | M7923 | |
| Pathway | REACTOME_EPH_EPHRIN_SIGNALING | 2.11e-03 | 65 | 15 | 2 | MM14911 | |
| Pathway | WP_PHYSICOCHEMICAL_FEATURES_AND_TOXICITYASSOCIATED_PATHWAYS | 2.18e-03 | 66 | 15 | 2 | M39642 | |
| Pathway | REACTOME_RHOB_GTPASE_CYCLE | 2.38e-03 | 69 | 15 | 2 | MM15596 | |
| Pathway | WP_ALZHEIMERS_DISEASE | 2.42e-03 | 261 | 15 | 3 | M42565 | |
| Pathway | REACTOME_RHOB_GTPASE_CYCLE | 2.45e-03 | 70 | 15 | 2 | M41806 | |
| Pathway | REACTOME_RHOC_GTPASE_CYCLE | 2.45e-03 | 70 | 15 | 2 | MM15597 | |
| Pathway | WP_AXON_GUIDANCE | 2.59e-03 | 72 | 15 | 2 | M48335 | |
| Pathway | REACTOME_RHOC_GTPASE_CYCLE | 2.73e-03 | 74 | 15 | 2 | M41807 | |
| Pathway | WP_LEPTIN_SIGNALING | 2.88e-03 | 76 | 15 | 2 | M39491 | |
| Pathway | REACTOME_G_ALPHA_12_13_SIGNALLING_EVENTS | 2.95e-03 | 77 | 15 | 2 | MM15044 | |
| Pathway | REACTOME_G_ALPHA_12_13_SIGNALLING_EVENTS | 3.18e-03 | 80 | 15 | 2 | M800 | |
| Pathway | WP_CLOCKCONTROLLED_AUTOPHAGY_IN_BONE_METABOLISM | 3.18e-03 | 80 | 15 | 2 | M45523 | |
| Pathway | REACTOME_PCP_CE_PATHWAY | 3.59e-03 | 85 | 15 | 2 | MM15041 | |
| Pathway | WP_MECHANISMS_ASSOCIATED_WITH_PLURIPOTENCY | 3.62e-03 | 301 | 15 | 3 | MM15983 | |
| Pathway | KEGG_TGF_BETA_SIGNALING_PATHWAY | 3.67e-03 | 86 | 15 | 2 | M2642 | |
| Pathway | WP_ANDROGEN_RECEPTOR_SIGNALING | 4.10e-03 | 91 | 15 | 2 | M39700 | |
| Pathway | REACTOME_EPH_EPHRIN_SIGNALING | 4.19e-03 | 92 | 15 | 2 | M27201 | |
| Pathway | REACTOME_PCP_CE_PATHWAY | 4.19e-03 | 92 | 15 | 2 | M27322 | |
| Pathway | REACTOME_CLASS_B_2_SECRETIN_FAMILY_RECEPTORS | 4.37e-03 | 94 | 15 | 2 | M797 | |
| Pathway | KEGG_PATHWAYS_IN_CANCER | 4.50e-03 | 325 | 15 | 3 | M12868 | |
| Pathway | WP_ALZHEIMERS_DISEASE_AND_MIRNA_EFFECTS | 4.54e-03 | 326 | 15 | 3 | M39379 | |
| Pathway | REACTOME_SIGNALING_BY_WNT | 4.69e-03 | 330 | 15 | 3 | M7847 | |
| Pathway | WP_INTEGRINMEDIATED_CELL_ADHESION | 5.12e-03 | 102 | 15 | 2 | M39577 | |
| Pathway | WP_INTEGRINMEDIATED_CELL_ADHESION | 5.12e-03 | 102 | 15 | 2 | MM15830 | |
| Pathway | REACTOME_SIGNALING_BY_VEGF | 5.22e-03 | 103 | 15 | 2 | MM14752 | |
| Pathway | REACTOME_SIGNALING_BY_VEGF | 5.52e-03 | 106 | 15 | 2 | M27077 | |
| Pathway | KEGG_VASCULAR_SMOOTH_MUSCLE_CONTRACTION | 6.46e-03 | 115 | 15 | 2 | M9387 | |
| Pathway | KEGG_LEUKOCYTE_TRANSENDOTHELIAL_MIGRATION | 6.57e-03 | 116 | 15 | 2 | M2164 | |
| Pathway | REACTOME_BETA_CATENIN_INDEPENDENT_WNT_SIGNALING | 7.36e-03 | 123 | 15 | 2 | MM14988 | |
| Pathway | KEGG_AXON_GUIDANCE | 8.07e-03 | 129 | 15 | 2 | M5539 | |
| Pubmed | 1.16e-08 | 10 | 17 | 3 | 15637299 | ||
| Pubmed | Expression patterns of Wnt genes during development of an anterior part of the chicken eye. | 1.16e-08 | 10 | 17 | 3 | 16258938 | |
| Pubmed | Wnt family proteins are secreted and associated with the cell surface. | 6.57e-08 | 17 | 17 | 3 | 8167409 | |
| Pubmed | 9.35e-08 | 19 | 17 | 3 | 11520664 | ||
| Pubmed | Epithelial Wnt10a Is Essential for Tooth Root Furcation Morphogenesis. | 1.28e-07 | 21 | 17 | 3 | 31914354 | |
| Pubmed | The WNT7b promoter is regulated by TTF-1, GATA6, and Foxa2 in lung epithelium. | 1.28e-07 | 21 | 17 | 3 | 11914369 | |
| Pubmed | 1.49e-07 | 22 | 17 | 3 | 18991257 | ||
| Pubmed | 1.71e-07 | 23 | 17 | 3 | 27362799 | ||
| Pubmed | Investigation of the esophageal Rho-kinase expression in patients with Barrett's esophagus. | 2.25e-07 | 2 | 17 | 2 | 23789633 | |
| Pubmed | 2.25e-07 | 2 | 17 | 2 | 28225294 | ||
| Pubmed | 2.25e-07 | 2 | 17 | 2 | 35523828 | ||
| Pubmed | 2.25e-07 | 2 | 17 | 2 | 15044207 | ||
| Pubmed | 2.25e-07 | 2 | 17 | 2 | 29115372 | ||
| Pubmed | ROCK1 mediates leukocyte recruitment and neointima formation following vascular injury. | 2.25e-07 | 2 | 17 | 2 | 18414683 | |
| Pubmed | ROCK2 inhibition enhances the thermogenic program in white and brown fat tissue in mice. | 2.25e-07 | 2 | 17 | 2 | 31914704 | |
| Pubmed | Investigation of the Rho-kinase Gene Polymorphism in Primary Open-angle Glaucoma. | 2.25e-07 | 2 | 17 | 2 | 24617500 | |
| Pubmed | Differential regulation of adhesion complex turnover by ROCK1 and ROCK2. | 2.25e-07 | 2 | 17 | 2 | 22348083 | |
| Pubmed | [Ouabain induces Rho-dependent rock activation and membrane blebbing incultured endothelial cells]. | 2.25e-07 | 2 | 17 | 2 | 25916120 | |
| Pubmed | Sulfide induces apoptosis and Rho kinase-dependent cell blebbing in Jurkat cells. | 2.25e-07 | 2 | 17 | 2 | 23479079 | |
| Pubmed | 2.25e-07 | 2 | 17 | 2 | 30771534 | ||
| Pubmed | Rho-associated kinase is a therapeutic target in neuroblastoma. | 2.25e-07 | 2 | 17 | 2 | 28739902 | |
| Pubmed | Matrix rigidity differentially regulates invadopodia activity through ROCK1 and ROCK2. | 2.25e-07 | 2 | 17 | 2 | 26826790 | |
| Pubmed | Evidence for Rho-kinase activation in patients with pulmonary arterial hypertension. | 2.25e-07 | 2 | 17 | 2 | 19590140 | |
| Pubmed | 2.25e-07 | 2 | 17 | 2 | 24429217 | ||
| Pubmed | 2.25e-07 | 2 | 17 | 2 | 12778124 | ||
| Pubmed | 2.25e-07 | 2 | 17 | 2 | 12165812 | ||
| Pubmed | 2.25e-07 | 2 | 17 | 2 | 24562870 | ||
| Pubmed | 2.25e-07 | 2 | 17 | 2 | 18495812 | ||
| Pubmed | 2.25e-07 | 2 | 17 | 2 | 25934709 | ||
| Pubmed | 2.25e-07 | 2 | 17 | 2 | 26468018 | ||
| Pubmed | 2.25e-07 | 2 | 17 | 2 | 29246448 | ||
| Pubmed | 2.25e-07 | 2 | 17 | 2 | 28035042 | ||
| Pubmed | ROCK insufficiency attenuates ozone-induced airway hyperresponsiveness in mice. | 2.25e-07 | 2 | 17 | 2 | 26276827 | |
| Pubmed | ROCK1 and ROCK2 regulate epithelial polarisation and geometric cell shape. | 2.25e-07 | 2 | 17 | 2 | 22462535 | |
| Pubmed | Fibroblast deletion of ROCK2 attenuates cardiac hypertrophy, fibrosis, and diastolic dysfunction. | 2.25e-07 | 2 | 17 | 2 | 28679962 | |
| Pubmed | Distinct Roles For ROCK1 and ROCK2 in the Regulation of Oxldl-Mediated Endothelial Dysfunction. | 2.25e-07 | 2 | 17 | 2 | 30165352 | |
| Pubmed | 2.25e-07 | 2 | 17 | 2 | 32877952 | ||
| Pubmed | 2.25e-07 | 2 | 17 | 2 | 30196430 | ||
| Pubmed | 2.25e-07 | 2 | 17 | 2 | 29800294 | ||
| Pubmed | 2.25e-07 | 2 | 17 | 2 | 27791202 | ||
| Pubmed | ROCK1/2 signaling contributes to corticosteroid-refractory acute graft-versus-host disease. | 2.25e-07 | 2 | 17 | 2 | 38199985 | |
| Pubmed | 2.25e-07 | 2 | 17 | 2 | 18668558 | ||
| Pubmed | 2.25e-07 | 2 | 17 | 2 | 17167780 | ||
| Pubmed | ROCK in CNS: Different Roles of Isoforms and Therapeutic Target for Neurodegenerative Disorders. | 2.25e-07 | 2 | 17 | 2 | 27033194 | |
| Pubmed | Role of Rho-kinase in regulation of insulin action and glucose homeostasis. | 2.25e-07 | 2 | 17 | 2 | 16098829 | |
| Pubmed | Association of Rho-kinase Gene Polymorphisms with Respiratory Distress Syndrome in Preterm Neonates. | 2.25e-07 | 2 | 17 | 2 | 27269648 | |
| Pubmed | Overexpression of ROCK1 and ROCK2 inhibits human laryngeal squamous cell carcinoma. | 2.25e-07 | 2 | 17 | 2 | 25755711 | |
| Pubmed | Hyperoxia increases the elastic modulus of alveolar epithelial cells through Rho kinase. | 2.25e-07 | 2 | 17 | 2 | 24289040 | |
| Pubmed | 2.25e-07 | 2 | 17 | 2 | 28709411 | ||
| Pubmed | 2.25e-07 | 2 | 17 | 2 | 32234882 | ||
| Pubmed | Targeting ROCK1/2 blocks cell division and induces mitotic catastrophe in hepatocellular carcinoma. | 2.25e-07 | 2 | 17 | 2 | 33278350 | |
| Pubmed | 2.25e-07 | 2 | 17 | 2 | 15096457 | ||
| Pubmed | Distinct roles for ROCK1 and ROCK2 in the regulation of cell detachment. | 2.25e-07 | 2 | 17 | 2 | 23392171 | |
| Pubmed | 2.25e-07 | 2 | 17 | 2 | 23250919 | ||
| Pubmed | 2.25e-07 | 2 | 17 | 2 | 28923399 | ||
| Pubmed | 2.25e-07 | 2 | 17 | 2 | 17347801 | ||
| Pubmed | 2.25e-07 | 2 | 17 | 2 | 21471517 | ||
| Pubmed | 2.25e-07 | 2 | 17 | 2 | 24168723 | ||
| Pubmed | Distinct distribution and localization of Rho-kinase in mouse epithelial, muscle and neural tissues. | 2.25e-07 | 2 | 17 | 2 | 22986902 | |
| Pubmed | Dissecting the roles of ROCK isoforms in stress-induced cell detachment. | 2.25e-07 | 2 | 17 | 2 | 23598717 | |
| Pubmed | Rho kinase inhibitors block melanoma cell migration and inhibit metastasis. | 2.25e-07 | 2 | 17 | 2 | 25840982 | |
| Pubmed | Activation of Rho kinase isoforms in lung endothelial cells during inflammation. | 2.25e-07 | 2 | 17 | 2 | 19201893 | |
| Pubmed | ROCK1 & 2 perform overlapping and unique roles in angiogenesis and angiosarcoma tumor progression. | 2.25e-07 | 2 | 17 | 2 | 22934846 | |
| Pubmed | ROCK-I and ROCK-II cooperatively regulate closure of eyelid and ventral body wall in mouse embryo. | 2.25e-07 | 2 | 17 | 2 | 16098146 | |
| Pubmed | ROCK regulates the intermittent mode of interstitial T cell migration in inflamed lungs. | 2.25e-07 | 2 | 17 | 2 | 29044117 | |
| Pubmed | Functional role of Rho-kinase in ameloblast differentiation. | 2.25e-07 | 2 | 17 | 2 | 21792909 | |
| Pubmed | Rho-kinase/ROCK: A key regulator of the cytoskeleton and cell polarity. | 2.25e-07 | 2 | 17 | 2 | 20803696 | |
| Pubmed | Role of Rho Kinase and Fasudil on Synaptic Plasticity in Multiple Sclerosis. | 2.25e-07 | 2 | 17 | 2 | 26481340 | |
| Pubmed | Distinct roles for ROCK1 and ROCK2 in the regulation of keratinocyte differentiation. | 2.25e-07 | 2 | 17 | 2 | 19997641 | |
| Pubmed | 2.25e-07 | 2 | 17 | 2 | 18331468 | ||
| Pubmed | 2.25e-07 | 2 | 17 | 2 | 29211497 | ||
| Pubmed | 2.25e-07 | 2 | 17 | 2 | 30369081 | ||
| Pubmed | 2.25e-07 | 2 | 17 | 2 | 29987023 | ||
| Pubmed | 2.25e-07 | 2 | 17 | 2 | 8772201 | ||
| Pubmed | Role of Rho kinase isoforms in murine allergic airway responses. | 2.25e-07 | 2 | 17 | 2 | 21565918 | |
| Pubmed | ROCK isoform regulation of myosin phosphatase and contractility in vascular smooth muscle cells. | 2.25e-07 | 2 | 17 | 2 | 19131646 | |
| Pubmed | Fasudil or genetic depletion of ROCK1 or ROCK2 induces anxiety-like behaviors. | 2.25e-07 | 2 | 17 | 2 | 31302146 | |
| Pubmed | Role of rho-kinase gene polymorphisms and protein expressions in colorectal cancer development. | 2.25e-07 | 2 | 17 | 2 | 23328676 | |
| Pubmed | The expression and prognostic value of ROCK I and ROCK II and their role in human breast cancer. | 2.25e-07 | 2 | 17 | 2 | 18695890 | |
| Pubmed | 2.25e-07 | 2 | 17 | 2 | 27203208 | ||
| Pubmed | 2.25e-07 | 2 | 17 | 2 | 20169147 | ||
| Pubmed | 2.25e-07 | 2 | 17 | 2 | 22355071 | ||
| Pubmed | The ROCK isoforms differentially regulate the morphological characteristics of carcinoma cells. | 2.25e-07 | 2 | 17 | 2 | 28650698 | |
| Pubmed | 2.25e-07 | 2 | 17 | 2 | 22942252 | ||
| Pubmed | Mesenchymal WNT-5A/5B Signaling Represses Lung Alveolar Epithelial Progenitors. | 2.25e-07 | 2 | 17 | 2 | 31557955 | |
| Pubmed | Genetic and pharmacological inhibition of Rho-associated kinase II enhances adipogenesis. | 2.25e-07 | 2 | 17 | 2 | 17681946 | |
| Pubmed | 2.25e-07 | 2 | 17 | 2 | 23946538 | ||
| Pubmed | 2.25e-07 | 2 | 17 | 2 | 24170433 | ||
| Pubmed | 2.25e-07 | 2 | 17 | 2 | 12508221 | ||
| Pubmed | The Rho kinase pathway regulates mouse adult neural precursor cell migration. | 2.25e-07 | 2 | 17 | 2 | 21732490 | |
| Pubmed | Rho kinases play an obligatory role in vertebrate embryonic organogenesis. | 2.25e-07 | 2 | 17 | 2 | 11532918 | |
| Pubmed | 2.25e-07 | 2 | 17 | 2 | 27251065 | ||
| Pubmed | Role of ROCK2 in CD4+ cells in allergic airways responses in mice. | 2.25e-07 | 2 | 17 | 2 | 27886408 | |
| Pubmed | ROCK2 Regulates Monocyte Migration and Cell to Cell Adhesion in Vascular Endothelial Cells. | 2.25e-07 | 2 | 17 | 2 | 30884801 | |
| Pubmed | 2.25e-07 | 2 | 17 | 2 | 18695640 | ||
| Pubmed | Comparative Study of ROCK1 and ROCK2 in Hippocampal Spine Formation and Synaptic Function. | 2.25e-07 | 2 | 17 | 2 | 30826947 | |
| Pubmed | Rho-associated kinases play a role in endocardial cell differentiation and migration. | 2.25e-07 | 2 | 17 | 2 | 15464581 | |
| Pubmed | 2.25e-07 | 2 | 17 | 2 | 22205227 | ||
| Pubmed | 3.15e-07 | 28 | 17 | 3 | 20940229 | ||
| Pubmed | Ectodermal Wnt signaling regulates abdominal myogenesis during ventral body wall development. | 3.15e-07 | 28 | 17 | 3 | 24394376 | |
| Interaction | WNT5B interactions | 6.69e-06 | 5 | 17 | 2 | int:WNT5B | |
| Interaction | WNT5A interactions | 2.52e-05 | 69 | 17 | 3 | int:WNT5A | |
| Interaction | TLN1 interactions | 5.99e-05 | 264 | 17 | 4 | int:TLN1 | |
| Interaction | PORCN interactions | 7.98e-05 | 16 | 17 | 2 | int:PORCN | |
| Interaction | HTRA3 interactions | 1.02e-04 | 18 | 17 | 2 | int:HTRA3 | |
| GeneFamily | Wnt family|Endogenous ligands | 5.46e-07 | 19 | 16 | 3 | 360 | |
| GeneFamily | Adenosine receptors|V-set domain containing | 8.92e-03 | 163 | 16 | 2 | 590 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 1.40e-02 | 206 | 16 | 2 | 682 | |
| GeneFamily | Endogenous ligands | 1.82e-02 | 237 | 16 | 2 | 542 | |
| Coexpression | CHANDRAN_METASTASIS_TOP50_DN | 2.95e-06 | 44 | 17 | 3 | M17043 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Crispld2_Kcne4|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.68e-05 | 156 | 17 | 3 | 896e2d958be0a5c62fb6eebad2dfb7e1ce69f3ad | |
| ToppCell | 390C-Fibroblasts-Fibroblast-B_(Myofibroblast)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 2.89e-05 | 160 | 17 | 3 | 636127753e3a22831f39d4c8170df40901e4329d | |
| ToppCell | 390C-Fibroblasts-Fibroblast-B_(Myofibroblast)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 2.89e-05 | 160 | 17 | 3 | cb8d0dc1a6c69c7a85c5fdd8f0f6cca1b73dfc63 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Crispld2_Kcne4|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.95e-05 | 161 | 17 | 3 | be77e99faf653480c166305df3a4e93db76f0dcb | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-Plasma_cells-IgG_plasma_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.17e-05 | 165 | 17 | 3 | 79c6ad394266ff092029375883660028e944a3c8 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell_prolif|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.23e-05 | 166 | 17 | 3 | 8e2faca6a2e76a625de04d6098aa6f98911945c6 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-CD8_cytotoxic-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.35e-05 | 168 | 17 | 3 | 50991eb794742592a0c96cd9a72460ab339e74ff | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.90e-05 | 191 | 17 | 3 | b2c86cde341fe350143658c8a8a4a9edbce3f19b | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.98e-05 | 192 | 17 | 3 | 3259cb89d6bcf0a3c6ff1f64d85e8a1f54124e91 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.06e-05 | 193 | 17 | 3 | 2e72309607902dabe3218888b22a77fe941f3570 | |
| ToppCell | ILEUM-inflamed-(7)_Endothelial_cell-(7)_CD36+_endothelial_cells|(7)_Endothelial_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 5.37e-05 | 197 | 17 | 3 | 66339b5aae3952f5c484c9dcb0cfb4fbd828d4cb | |
| ToppCell | (02)_MMP9/10+-(2)_GFP_FOXI1|(02)_MMP9/10+ / shred by cell type by condition | 5.54e-05 | 199 | 17 | 3 | 18a7f9ced4364f45b184bd529f32ef02c27779d3 | |
| ToppCell | Thalamus-Hematopoietic-MACROPHAGE-MP1(C1qb)-MACROPHAGE_Macrophage.C1qb.Mrc1_(Resident_macrophage)|Thalamus / BrainAtlas - Mouse McCarroll V32 | 8.01e-04 | 111 | 17 | 2 | 567e5ac2c78d45db207067f0f152bb24ed048c50 | |
| ToppCell | Thalamus-Hematopoietic-MACROPHAGE-MP1(C1qb)-MACROPHAGE_Macrophage.C1qb.Mrc1_(Resident_macrophage)-|Thalamus / BrainAtlas - Mouse McCarroll V32 | 8.01e-04 | 111 | 17 | 2 | d1ec8e8e9adb11511b4ef363cc6f99286e2cc842 | |
| ToppCell | Thalamus-Hematopoietic-MACROPHAGE-MP1(C1qb)|Thalamus / BrainAtlas - Mouse McCarroll V32 | 8.01e-04 | 111 | 17 | 2 | fd7aa25e83a0d762969e3966a658652da40c490e | |
| ToppCell | Thalamus-Hematopoietic-MACROPHAGE|Thalamus / BrainAtlas - Mouse McCarroll V32 | 8.01e-04 | 111 | 17 | 2 | d48561078c387ac856c1c30e3d7a3e75ebde942e | |
| ToppCell | Thalamus-Hematopoietic-MACROPHAGE-MP1(C1qb)-MACROPHAGE_Macrophage.C1qb.Mrc1_(Resident_macrophage)--|Thalamus / BrainAtlas - Mouse McCarroll V32 | 8.01e-04 | 111 | 17 | 2 | a1b7940c6fa0e5a58aa4798b604469d79f33fa44 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Myh8_Fibin|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 8.30e-04 | 113 | 17 | 2 | feb3c6a7723263d58e5ce020a0097fedfcf78ca8 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Serpinf1-Serpinf1_Clrn1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 9.04e-04 | 118 | 17 | 2 | 702548d8187d54e8814375e5ae7609631fc71d5f | |
| ToppCell | COVID-19-kidney-Mito-rich_Int|COVID-19 / Disease (COVID-19 only), tissue and cell type | 9.66e-04 | 122 | 17 | 2 | a4220adb4e6055a599bd9bbf65d460fc4e68b543 | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-C1ql2-Excitatory_Neuron.Slc17a7.C1ql2-Cck_(Dentate_Principal_cells)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.08e-03 | 129 | 17 | 2 | 08ecebb7f09d105dfdfd2191fc310910d3baec0f | |
| ToppCell | (08)_Brush+PNEC-(2)_GFP_FOXI1|(08)_Brush+PNEC / shred by cell type by condition | 1.23e-03 | 138 | 17 | 2 | 817e3f639604ea95adae01e8685ffaa2e0aff7a8 | |
| ToppCell | TCGA-Bile_Duct|World / Sample_Type by Project: Shred V9 | 1.27e-03 | 140 | 17 | 2 | ca8a0ccbc2f501b759864fe9bb06dc8b44b6b31f | |
| ToppCell | COVID-19_Moderate-B_cell|COVID-19_Moderate / disease group, cell group and cell class | 1.30e-03 | 142 | 17 | 2 | 88bb8d9bca66131df4ee7021b88248e146aa7aa6 | |
| ToppCell | Goblet-gob-2|World / Class top | 1.30e-03 | 142 | 17 | 2 | 9b058dc313d1f0edcd8473e342852632e17536a6 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Lmo1_Myl1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.34e-03 | 144 | 17 | 2 | 0322fef818a963be00535d5f141f028d43de5c6a | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Lmo1_Myl1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.36e-03 | 145 | 17 | 2 | 590ba937c741ae67460f303eca88b1cd3ac87f64 | |
| ToppCell | facs-Pancreas-Endocrine-18m-Epithelial-pancreatic_acinar_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.38e-03 | 146 | 17 | 2 | cb19f2bb6832d11fe69b670df49eac096a378a9d | |
| ToppCell | 343B-Lymphocytic-CD8+_Cytotoxic_T-cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.38e-03 | 146 | 17 | 2 | bb7bf20245d93c8812920dd0debbf1ed00add378 | |
| ToppCell | facs-Pancreas-Endocrine-18m-Epithelial-pancreatic_acinar_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.38e-03 | 146 | 17 | 2 | 74009a2921359a8352afbaea8c325a3743622543 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_B-Plasma_cell-B_c06-MKI67|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.40e-03 | 147 | 17 | 2 | 22d71cf92b957e5a8aa63b13157626d013d6752b | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Lmo1_Fam159b|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.42e-03 | 148 | 17 | 2 | 9205b26e0d042b342cc643cda0f4f3f8bb392d00 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Lmo1_Fam159b|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.43e-03 | 149 | 17 | 2 | 98ae408d2d0347865875ff8bbd89d359decea526 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Serpinf1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.43e-03 | 149 | 17 | 2 | 5293c50b3fb41b1edaf9a97354899bd13770078c | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_B|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.45e-03 | 150 | 17 | 2 | 53de595376a9fc92491dfd58ff25938b0bf79903 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_B-B_cell|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.45e-03 | 150 | 17 | 2 | e4b40b3243ed26d0c46bf196ac06e148834e7ed2 | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_naive-B_naive-9|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.47e-03 | 151 | 17 | 2 | 2314c004434aed9b7fa1ad01c61c43e5ed4a18ce | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.51e-03 | 153 | 17 | 2 | edf5d026e8e4c685b7c369d70894741bb2cd568e | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.51e-03 | 153 | 17 | 2 | 3240d4d690335ba22317b1f3d33f9ea069e93838 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell_prolif|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.53e-03 | 154 | 17 | 2 | e51a5114f0ec38f997f5b8bbf3a7770f98595474 | |
| ToppCell | tumor_Lymph_Node_/_Brain-B_lymphocytes-Undetermined|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 1.53e-03 | 154 | 17 | 2 | e16f200391537aa1002b0079481b94e1fb86b9ad | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.53e-03 | 154 | 17 | 2 | ec56b7fb88e39041416c384f371c767f3b4e92fa | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Rspo4_Rxfp1_Chat|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.55e-03 | 155 | 17 | 2 | 3b8def9e8f66511736ea37f259511f7c8b7743af | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_bronchial_vessel-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.57e-03 | 156 | 17 | 2 | ff39712c7a2dc1b85c598d5105789aa291dea726 | |
| ToppCell | IIH-CD8-memory_CD4|IIH / Condition, Cell_class and T cell subcluster | 1.57e-03 | 156 | 17 | 2 | e312fc4317d966fb2b570d1a4a3aa865f781ea93 | |
| ToppCell | facs-Spleen-nan-3m-Myeloid-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.57e-03 | 156 | 17 | 2 | da4f35353a84d919e683554932f110e29568df33 | |
| ToppCell | facs-Spleen-nan-3m-Myeloid-granulocyte|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.57e-03 | 156 | 17 | 2 | f1e25ff85c5f2f8555f9fb5ae5daed7ddb418fd1 | |
| ToppCell | facs-Spleen-nan-3m-Myeloid|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.57e-03 | 156 | 17 | 2 | f532ef4e92ac7661b1a8a4f2e98d80ce8d4e3655 | |
| ToppCell | facs-Marrow-T-cells-24m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.59e-03 | 157 | 17 | 2 | ed9c9feefc06c9536c03bedbc3397a2ee492a78e | |
| ToppCell | facs-Marrow-T-cells-24m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.59e-03 | 157 | 17 | 2 | fddcb24776b9f86e000208bae54541b15b2adefd | |
| ToppCell | facs-Lung-Endomucin-24m-Myeloid-neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.61e-03 | 158 | 17 | 2 | b3a810314e253b4fd0f578e759c36fdd21722934 | |
| ToppCell | facs-Lung-Endomucin-24m-Myeloid-Neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.61e-03 | 158 | 17 | 2 | 0ed844ab625351a46b74edddf082279ed1bae5c6 | |
| ToppCell | COVID-naiveBc|COVID / Condition, Cell_class and T cell subcluster | 1.63e-03 | 159 | 17 | 2 | 52cd36b4412f69a935b3f76da96c166a9481eb0c | |
| ToppCell | COVID-naiveBc-|COVID / Condition, Cell_class and T cell subcluster | 1.63e-03 | 159 | 17 | 2 | 4e6783b0f69c0c70150f9f3594881dc1bac7038a | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell_prolif|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.65e-03 | 160 | 17 | 2 | 830e3ef8c9708d25872c3052a0b2682fa9372111 | |
| ToppCell | LAM-Lymphoid-B-cell-2|LAM / Condition, Lineage and Cell class | 1.65e-03 | 160 | 17 | 2 | 0060c2b3304f411c682aa2ba20bcf80f346d2403 | |
| ToppCell | facs-Marrow-T-cells-24m-Hematologic-MPP_Fraction_B|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.65e-03 | 160 | 17 | 2 | b3f7ef7e682b48a83ca425f5c439336e96168300 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_goblet_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.67e-03 | 161 | 17 | 2 | 2d63b279d9a5132e1c09b03930bf9039036d24a2 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell_prolif|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.71e-03 | 163 | 17 | 2 | 1feb4ef7b8abcfca9a72c8d13c40548de79e7db2 | |
| ToppCell | 343B-Lymphocytic-Plasma_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.73e-03 | 164 | 17 | 2 | cf62d34ce9dd220fe61748466c84fd70d9ba697c | |
| ToppCell | 343B-Lymphocytic-Plasma_cell-|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.73e-03 | 164 | 17 | 2 | e00549bc8b3a5566f39031f39d7e698b0b107a7f | |
| ToppCell | Endothelial-endothelial_cell_of_bronchial_vessel|World / Lineage, Cell type, age group and donor | 1.75e-03 | 165 | 17 | 2 | 84e553d699ac56df89a77248f7308b9133e1b683 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Myeloid-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.75e-03 | 165 | 17 | 2 | 7f293f64e7df7710b13016937cdd4f1af326f8c3 | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-03 | 166 | 17 | 2 | b21e45bd43f26149b9cd6e45c19241c82d54fb2f | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-03 | 166 | 17 | 2 | 13027ae342994db4540e64eb910df1f42b160931 | |
| ToppCell | facs-Lung-EPCAM-24m-Endothelial-Lymphatic_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.80e-03 | 167 | 17 | 2 | 961e722442d786ab15d1e490941d2be265a9057a | |
| ToppCell | facs-Lung-EPCAM-24m-Endothelial-endothelial_cell_of_lymphatic_vessel|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.80e-03 | 167 | 17 | 2 | 3760efc35d4e7e9c2da1a20f9795ddea397e2206 | |
| ToppCell | 367C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.84e-03 | 169 | 17 | 2 | 225aec04ba762d4c55885257de03a65b63503fbb | |
| ToppCell | 367C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.84e-03 | 169 | 17 | 2 | 278960f940b646a788360b1c84d641a8d169896b | |
| ToppCell | 3'-Broncho-tracheal-Endothelial-Blood_vessel_EC-capillary_endothelial_cell-EC_general_capillary-EC_general_capillary_L.2.0.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.84e-03 | 169 | 17 | 2 | 0d8b681404e18f3061d84425fb5f7d84e8e2b8d7 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Ptprt_Pkp2|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.86e-03 | 170 | 17 | 2 | 14aa86a4f526ed6986afcb28c49225522055550c | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.86e-03 | 170 | 17 | 2 | 928e42c51a7079c506f21c669c4e4c1a0df84d77 | |
| ToppCell | BAL-Mild-Lymphocyte-B-B_cell-B_cell-B_activate-7|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.86e-03 | 170 | 17 | 2 | ee2ee67d90ae4596de8ccd620e37c82cf51651d4 | |
| ToppCell | BAL-Mild-Lymphocyte-B-B_cell-B_cell|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.86e-03 | 170 | 17 | 2 | d7ca0c6ce5d2b7de99346f87e07aa7fe728fa08a | |
| ToppCell | NS-critical-d_0-4-Myeloid-Monocyte-derived_Macrophage|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.86e-03 | 170 | 17 | 2 | adf73bdc049d508f8873c22539db2ca92052a97b | |
| ToppCell | BAL-Mild-Lymphocyte-B-B_cell|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.86e-03 | 170 | 17 | 2 | 52787f6d529c285d9f0c04cc022710ead5b89b3f | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|Heart / Disease (COVID-19 only), tissue and cell type | 1.86e-03 | 170 | 17 | 2 | 4232fe937909f93d3736988c707b8f95ce993398 | |
| ToppCell | Myeloid-Myeloid-D_(Mast_cell)|Myeloid / shred on cell class and cell subclass (v4) | 1.88e-03 | 171 | 17 | 2 | 5f1aafc4c55a9c6c3153430186a8a351425a3cb9 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.88e-03 | 171 | 17 | 2 | 5efd15300f865ebf651e0888265cbd717bc3b9d3 | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Endothelial-blood_vessel_EC-venous_capillary|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.88e-03 | 171 | 17 | 2 | b3e6e31dfe3623b960ccf692fdbd236fa4039923 | |
| ToppCell | droplet-Liver-Hepatocytes-21m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.90e-03 | 172 | 17 | 2 | 574ebdf36e45222bcd907cd2c2ee7ff50ed4573a | |
| ToppCell | droplet-Liver-Hepatocytes-21m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.90e-03 | 172 | 17 | 2 | 1627fa7035b0e0bbc82a1c0f000d8231254c680a | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.90e-03 | 172 | 17 | 2 | 7e1a7700a4c2b1d100da1d6e475e73498ebb605a | |
| ToppCell | droplet-Liver-nan-3m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.90e-03 | 172 | 17 | 2 | 1f335ccb92b22d0412954e8fc3af212f96410b67 | |
| ToppCell | 3'_v3-lymph-node_spleen-Myeloid_Dendritic-migDC|lymph-node_spleen / Manually curated celltypes from each tissue | 1.90e-03 | 172 | 17 | 2 | 1b24bed3cd8e3fa463c5e7cefdf9e99e639e2f84 | |
| ToppCell | droplet-Liver-nan-3m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.90e-03 | 172 | 17 | 2 | bb96c896d125e10b71e94e2bdad243899045af5c | |
| ToppCell | PBMC-Control-Myeloid-cDC-cDC-cDC_10|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.92e-03 | 173 | 17 | 2 | 09a13407a41ff2cba82fc417b72bf9a24ce6c42e | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-Plasma_cells-IgA_plasma_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.92e-03 | 173 | 17 | 2 | 68bcc0eee15df9cf3516c641709154301bd7b38f | |
| ToppCell | PBMC-Control-Myeloid-cDC-cDC-cDC_10|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.92e-03 | 173 | 17 | 2 | bfec038a6783f166240da4861e100643c6ea80a5 | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-Basophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.92e-03 | 173 | 17 | 2 | 53e97835d7a518c278e7b90a0734eb0095d6aa33 | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-Basophil/Mast_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.92e-03 | 173 | 17 | 2 | 117163c5cd2b7aaa1c0682c8ac44b4249df4d2f8 | |
| ToppCell | Plasma_cells|World / lung cells shred on cell class, cell subclass, sample id | 1.92e-03 | 173 | 17 | 2 | 52a387e2a4694af61a9223a4c2ecf4e6f762c064 | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-basophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.92e-03 | 173 | 17 | 2 | 889a880de5fc19d26b82cfef3067869a28ef17ca | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-Basophil/Mast_cell-basophil_l26|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.92e-03 | 173 | 17 | 2 | 01df9baeedf30e3a4891738554cdd300394dbb96 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_FAM150B|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.95e-03 | 174 | 17 | 2 | cc4c7f00a25a7814b52d4599166615daa140cc31 | |
| ToppCell | TCGA-Liver|World / Sample_Type by Project: Shred V9 | 1.95e-03 | 174 | 17 | 2 | 452932f08cf53e5949672a025d78cecb874aa4b0 | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-non-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.97e-03 | 175 | 17 | 2 | c8cfe0ac0c1ac447c626a623cc49692a0b177a1c | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-Nonclassical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.97e-03 | 175 | 17 | 2 | 61fbd8f685d3daad46449e4c0386a38886496566 | |
| ToppCell | TCGA-Colorectal-Recurrent_Tumor|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 1.97e-03 | 175 | 17 | 2 | 7f74961436f88c0e380819095e6104489914d765 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-3m-Endothelial-endothelial_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.97e-03 | 175 | 17 | 2 | c1e082538f31b5c98ac63f71dcca4a1211a14708 | |
| Drug | Rockout | 5.25e-07 | 2 | 17 | 2 | CID000644354 | |
| Drug | 3,3-dimethylacryloyl chloride | 5.25e-07 | 2 | 17 | 2 | CID000102394 | |
| Drug | diguanosine pentaphosphate | 3.15e-06 | 4 | 17 | 2 | CID004577574 | |
| Drug | tetrahydrooxazine | 5.24e-06 | 5 | 17 | 2 | CID000449101 | |
| Drug | brazilein | 7.86e-06 | 6 | 17 | 2 | CID006453902 | |
| Drug | levormeloxifene | 7.86e-06 | 6 | 17 | 2 | ctd:C108255 | |
| Drug | AC1L1CTF | 7.86e-06 | 6 | 17 | 2 | CID000002056 | |
| Drug | 6-BME | 1.10e-05 | 7 | 17 | 2 | CID005748218 | |
| Drug | AC1L2VEC | 1.10e-05 | 7 | 17 | 2 | CID000129320 | |
| Drug | heptenoic acid | 1.47e-05 | 8 | 17 | 2 | CID000029373 | |
| Drug | N-palmitoyl-serine | 1.47e-05 | 8 | 17 | 2 | CID000085997 | |
| Drug | oxethazaine | 1.47e-05 | 8 | 17 | 2 | CID000004621 | |
| Drug | GGTI-297 | 1.47e-05 | 8 | 17 | 2 | CID009956145 | |
| Drug | SC-46275 | 1.47e-05 | 8 | 17 | 2 | CID005311427 | |
| Drug | Y-26763 | 1.47e-05 | 8 | 17 | 2 | CID000121878 | |
| Drug | P6Chol | 1.88e-05 | 9 | 17 | 2 | CID000126085 | |
| Drug | MCI-154 | 2.87e-05 | 11 | 17 | 2 | CID000123941 | |
| Drug | oxanol | 3.45e-05 | 12 | 17 | 2 | CID000136505 | |
| Drug | DMEP | 3.45e-05 | 12 | 17 | 2 | CID000008344 | |
| Drug | 2-MeSAMP | 4.07e-05 | 13 | 17 | 2 | CID000189762 | |
| Drug | LFA703 | 4.07e-05 | 13 | 17 | 2 | CID000449169 | |
| Drug | B-43 | 4.75e-05 | 14 | 17 | 2 | CID006603792 | |
| Drug | cBiMPS | 4.75e-05 | 14 | 17 | 2 | CID005487206 | |
| Drug | AC1L1JG6 | 4.75e-05 | 14 | 17 | 2 | CID000005026 | |
| Drug | AC1N7NQV | 4.75e-05 | 14 | 17 | 2 | CID004330476 | |
| Drug | U46619 | 5.03e-05 | 285 | 17 | 4 | CID000005618 | |
| Drug | PD150606 | 5.48e-05 | 15 | 17 | 2 | CID009839500 | |
| Drug | NSC-114340 | 6.26e-05 | 16 | 17 | 2 | CID000004598 | |
| Drug | un-3 | 6.26e-05 | 16 | 17 | 2 | CID005327154 | |
| Drug | GR 55562 | 7.97e-05 | 18 | 17 | 2 | CID000128017 | |
| Drug | PC-PI | 7.97e-05 | 18 | 17 | 2 | CID000007693 | |
| Drug | RS 102221 | 7.97e-05 | 18 | 17 | 2 | CID003693566 | |
| Drug | AC1L18QD | 8.38e-05 | 325 | 17 | 4 | CID000000213 | |
| Drug | A3846_sigma | 1.09e-04 | 21 | 17 | 2 | CID005311238 | |
| Drug | JTE-013 | 1.09e-04 | 21 | 17 | 2 | CID010223146 | |
| Drug | (3Z)-3-[3-(hydroxyamino)indolin-2-ylidene]oxindole | 1.09e-04 | 21 | 17 | 2 | CID016073041 | |
| Drug | AC1LA1RA | 1.20e-04 | 22 | 17 | 2 | CID000479966 | |
| Drug | AC1L1CU6 | 1.32e-04 | 23 | 17 | 2 | CID000002065 | |
| Drug | SB204741 | 1.43e-04 | 24 | 17 | 2 | CID003277600 | |
| Drug | avanafil | 1.43e-04 | 24 | 17 | 2 | CID009869929 | |
| Drug | homopiperazine | 1.56e-04 | 25 | 17 | 2 | CID000068163 | |
| Drug | nicardipine | 1.61e-04 | 145 | 17 | 3 | CID000004473 | |
| Drug | Ro-26-9228 | 1.69e-04 | 26 | 17 | 2 | CID009889588 | |
| Drug | AC1Q6S45 | 1.82e-04 | 27 | 17 | 2 | CID000000508 | |
| Drug | Ro 44-9883 | 2.41e-04 | 31 | 17 | 2 | CID000071453 | |
| Drug | cyclohexanecarboxamide | 2.57e-04 | 32 | 17 | 2 | CID000014283 | |
| Drug | AC1L1CTC | 2.57e-04 | 32 | 17 | 2 | CID000002055 | |
| Drug | STO-609 | 2.57e-04 | 32 | 17 | 2 | CID003467590 | |
| Drug | SEW2871 | 2.57e-04 | 32 | 17 | 2 | CID004077460 | |
| Drug | AC1L9XAW | 2.73e-04 | 33 | 17 | 2 | CID000477669 | |
| Drug | A61603 | 2.73e-04 | 33 | 17 | 2 | CID004038180 | |
| Drug | C15H20O3 | 2.80e-04 | 175 | 17 | 3 | CID000004692 | |
| Drug | Endosulfan | 2.85e-04 | 447 | 17 | 4 | ctd:D004726 | |
| Drug | AC1NSKHR | 2.90e-04 | 34 | 17 | 2 | CID005311362 | |
| Drug | damnacanthal | 2.90e-04 | 34 | 17 | 2 | CID000002948 | |
| Drug | GGTI-286 | 3.08e-04 | 35 | 17 | 2 | CID003012116 | |
| Drug | MAPTAM | 3.44e-04 | 37 | 17 | 2 | CID000123719 | |
| Drug | Seneciphylline [480-81-9]; Down 200; 12uM; MCF7; HT_HG-U133A | 3.51e-04 | 189 | 17 | 3 | 2797_DN | |
| Drug | Luteolin [491-70-3]; Down 200; 14uM; MCF7; HT_HG-U133A | 3.57e-04 | 190 | 17 | 3 | 3379_DN | |
| Drug | CP-319743 [172078-87-4]; Up 200; 10uM; MCF7; HT_HG-U133A | 3.62e-04 | 191 | 17 | 3 | 7486_UP | |
| Drug | fasudil | 3.63e-04 | 38 | 17 | 2 | ctd:C049347 | |
| Drug | Glafenine hydrochloride [65513-72-6]; Down 200; 9.8uM; MCF7; HT_HG-U133A | 3.74e-04 | 193 | 17 | 3 | 7418_DN | |
| Drug | 12-deoxyphorbol 13-isobutyrate | 3.83e-04 | 39 | 17 | 2 | CID000107855 | |
| Drug | Dichlorphenamide [120-97-8]; Up 200; 13.2uM; MCF7; HT_HG-U133A | 3.85e-04 | 195 | 17 | 3 | 3366_UP | |
| Drug | Cephalothin sodium salt [58-71-9]; Up 200; 9.6uM; HL60; HT_HG-U133A | 3.85e-04 | 195 | 17 | 3 | 2517_UP | |
| Drug | Esculetin [305-01-1]; Down 200; 22.4uM; HL60; HT_HG-U133A | 3.85e-04 | 195 | 17 | 3 | 3120_DN | |
| Drug | Mefloquine hydrochloride [51773-92-3]; Down 200; 9.6uM; PC3; HT_HG-U133A | 3.91e-04 | 196 | 17 | 3 | 5724_DN | |
| Drug | Merbromin [129-16-8]; Up 200; 5uM; PC3; HT_HG-U133A | 3.91e-04 | 196 | 17 | 3 | 3700_UP | |
| Drug | Benzthiazide [91-33-8]; Down 200; 9.2uM; PC3; HT_HG-U133A | 3.97e-04 | 197 | 17 | 3 | 6607_DN | |
| Drug | Reserpinic acid hydrochloride; Up 200; 9.2uM; MCF7; HT_HG-U133A | 3.97e-04 | 197 | 17 | 3 | 4948_UP | |
| Drug | Aminohippuric acid [61-78-9]; Up 200; 20.6uM; MCF7; HT_HG-U133A | 3.97e-04 | 197 | 17 | 3 | 5394_UP | |
| Drug | Selegiline hydrochloride [14611-52-0]; Up 200; 17.8uM; HL60; HT_HG-U133A | 3.97e-04 | 197 | 17 | 3 | 2465_UP | |
| Drug | Stachydrine hydrochloride; Up 200; 22.2uM; MCF7; HT_HG-U133A | 3.97e-04 | 197 | 17 | 3 | 6805_UP | |
| Drug | LY 294002; Up 200; 0.1uM; PC3; HT_HG-U133A | 3.97e-04 | 197 | 17 | 3 | 1216_UP | |
| Drug | sodium bisulfide | 4.03e-04 | 40 | 17 | 2 | ctd:C025451 | |
| Drug | SB216763 | 4.03e-04 | 40 | 17 | 2 | CID000176158 | |
| Drug | Aztreonam [78110-38-0]; Up 200; 9.2uM; PC3; HT_HG-U133A | 4.03e-04 | 198 | 17 | 3 | 2118_UP | |
| Drug | Tacrine hydrochloride hydrate [1684-40-8]; Down 200; 15.8uM; MCF7; HT_HG-U133A | 4.03e-04 | 198 | 17 | 3 | 2633_DN | |
| Drug | estradiol; Up 200; 0.01uM; MCF7; HT_HG-U133A | 4.03e-04 | 198 | 17 | 3 | 5905_UP | |
| Drug | Bretylium tosylate [61-75-6]; Down 200; 9.6uM; PC3; HT_HG-U133A | 4.09e-04 | 199 | 17 | 3 | 6674_DN | |
| Drug | methenamine silver | 4.21e-04 | 201 | 17 | 3 | CID000004101 | |
| Drug | Cgp77675 | 4.65e-04 | 43 | 17 | 2 | CID005311381 | |
| Drug | darifenicin | 4.65e-04 | 43 | 17 | 2 | CID000072054 | |
| Drug | Pkcs | 4.85e-04 | 211 | 17 | 3 | CID000164073 | |
| Drug | SC-560 | 4.87e-04 | 44 | 17 | 2 | CID004306515 | |
| Drug | AH6809 | 5.10e-04 | 45 | 17 | 2 | CID000119461 | |
| Drug | AC1L9GCG | 5.33e-04 | 46 | 17 | 2 | CID000444451 | |
| Drug | thromboxane | 5.70e-04 | 223 | 17 | 3 | CID000114873 | |
| Drug | tipifarnib | 6.81e-04 | 52 | 17 | 2 | ctd:C402769 | |
| Drug | Chromium | 6.88e-04 | 238 | 17 | 3 | ctd:D002857 | |
| Disease | Cholestasis | 1.60e-03 | 110 | 16 | 2 | C0008370 | |
| Disease | total blood protein measurement | 1.69e-03 | 449 | 16 | 3 | EFO_0004536 | |
| Disease | spine bone mineral density | 1.87e-03 | 119 | 16 | 2 | EFO_0007701 | |
| Disease | type 2 diabetes mellitus (is_marker_for) | 2.43e-03 | 136 | 16 | 2 | DOID:9352 (is_marker_for) | |
| Disease | stroke | 2.71e-03 | 144 | 16 | 2 | EFO_0000712 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GSYCFRGGVGWWKYE | 341 | Q96DZ1 | |
| RGGVGWWKYEFCYGK | 346 | Q96DZ1 | |
| AAGYWVLGLWNGCEY | 416 | Q6UXG8 | |
| YGSGWETYLKWRCQG | 41 | Q6UXZ3 | |
| EDWWYGSIGKGQEGY | 1086 | Q8N157 | |
| DGYGGNYNSQGVDWW | 646 | O00571 | |
| RAYWTGYGEGNAWCP | 121 | Q86VF7 | |
| VGSDGYVYEGRGWHW | 451 | Q96PD5 | |
| WYGDEYGQELGIKWG | 356 | Q9NQV7 | |
| EENCAEVYGGGWWYN | 796 | P02671 | |
| GEYRDWKAWGGYNGE | 1291 | Q9Y4K1 | |
| YWGGGCRLWEGMGDE | 451 | P52429 | |
| WSWGSCAVYDSGGYV | 3806 | P98161 | |
| WLWGGCGDNVEYGYR | 156 | Q9H1J7 | |
| GGDGFYGRECDWWSV | 266 | O75116 | |
| EGWHWGGCSDDVQYG | 161 | Q9UBV4 | |
| DWLWGGCGDNIDYGY | 176 | P41221 | |
| GDGYYGRECDWWSVG | 251 | Q13464 |